Prostate cancer: to screen or not to screen?

No abstract is available for this paper.

• Publication year

  1993

• Venue

  British medical journal

• Publication date

  1993-02-13

• Fields of study

  Medicine

• Identifiers
  DOI 10.1136/bmj.306.6875.407PMID 8338522PMCID PMC1676503
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Modalities available for screening for prostate cancer.

  1993cited by this paper
• Distribution of Leu-7 antigen (HNK-1) in thyroid tumors: its usefulness as a diagnostic marker for follicular and papillary carcinomas.

  1992cited by this paper
• Early detection of prostate cancer.

  1992cited by this paper
• Current urological practice: routine urological examination and early detection of carcinoma of the prostate.

  1992cited by this paper
• Radical prostatectomy in locally confined prostatic carcinoma.

  1990cited by this paper
• Cancer in the European Community and its member states.

  1990cited by this paper
• Total prostatectomy for clinically localized prostatic cancer: long-term results.

  1989cited by this paper
• A controlled trial of leuprolide with and without flutamide in prostatic carcinoma.

  1989cited by this paper
• Stage D1 adenocarcinoma of prostate.

  1984cited by this paper
• Latent carcinoma of the prostate.

  1954cited by this paper

• Diagnostic performance of microRNAs in the circulation in differential diagnosis of BPH, chronic prostatitis and prostate cancer

  2018cites this paper
• ASSOCIAÇÃO MÉDICA BRASILEIRA

  2016cites this paper
• Biomarker development, from bench to bedside

  2016cites this paper
• Active surveillance for prostate cancer: a legal perspective.

  2014cites this paper
• Umbilical hernia

  2013cites this paper
• Trends in prostate cancer incidence and mortality in a mid-sized Northeastern Brazilian city.

  2013cites this paper
• [Gonadotrophin releasing hormone analogues in prostatic cancer: can we consider them truly equivalent?].

  2013cites this paper
• Análogos de la hormona liberadora de gonadotropinas en cáncer de próstata: ¿podemos considerarlos en realidad equivalentes?

  2013cites this paper
• Anticancer Activity of Green Tea Polyphenols in Prostate Gland

  2012cites this paper
• The European Randomized Study of Screening for Prostate Cancer (ERSPC).

  2010cites this paper
• Gene Promoter Methylation and Its Potential Relevance in Early Prostate Cancer Diagnosis

  2010cites this paper
• Biopsy, Diagnosis, and Staging of Prostate Cancer

  2009cites this paper
• Prostate cancer and urinary incontinence.

  2009cites this paper
• Evaluation of serum and urinary myeloid related protein-14 as a marker for early detection of prostate cancer.

  2008cites this paper
• Is familie-onderzoek aan te bevelen bij familiair voorkomen van prostaatcarcinoom?

  2006cites this paper
• Nomograms for prostate cancer

  2006cites this paper
• Prediction of indolent prostate cancer: validation and updating of a prognostic nomogram.

  2006cites this paper
• Detection rates of high‐grade prostate cancer during subsequent screening visits. Results of the European Randomized Screening Study for Prostate Cancer

  2006cites this paper
• Prevention of hormone-related cancers: prostate cancer.

  2005cites this paper
• Screening in urology

  2004cites this paper
• Screening for prostate cancer

  2004cites this paper
• European Randomized Study of Screening for Prostate Cancer: achievements and presentation

  2003cites this paper
• Nuclear matrix proteins changes in cancerous prostate tissues and their prognostic value in clinically localized prostate cancer

  2003cites this paper
• The story of the European Randomized Study of Screening for Prostate Cancer

  2003cites this paper
• Features and preliminary results of the Dutch centre of the ERSPC (Rotterdam, the Netherlands)

  2003cites this paper
• Philosophy of public health: lessons from its history in England.

  2002cites this paper
• Screening for prostate cancer with prostate-specific antigen: beware the biases.

  2002cites this paper
• SCREENING AND CLINICAL MANAGEMENT OF PROSTATE CANCER

  2001cites this paper
• Diagnosis, Characterization and Potential Clinical Relevance of Prostate Cancer Detected at Low PSA Ranges

  2001cites this paper
• [Genetics of prostate cancer].

  2001cites this paper
• Situación diagnóstica del cáncer de próstata en atención primaria

  2000cites this paper
• [The diagnostic situation with prostatic cancer in primary care].

  2000cites this paper
• Current challenges in cancer screening. Part II. Prostate cancer screening.

  2000cites this paper
• Trends in prostate cancer incidence, mortality and survival in England and Wales 1971–1998

  2000cites this paper
• Part II. Prostate cancer screening

  2000cites this paper
• Neoadjuvant hormonal therapy in carcinoma of the prostate

  1999cites this paper
• Towards a philosophy of public health.

  1999cites this paper
• Lack of knowledge regarding prostate-specific antigen screening: is ignorance bliss?

  1999cites this paper
• Final Results of a Screening Campaign for Prostate Cancer

  1999cites this paper
• Cancer of the prostate. 3: Men's healthcare needs.

  1998cites this paper
• Prostatic cancer screening—does it fulfil the criteria for medical screening?

  1998cites this paper
• Prostate cancer: screening or watchful waiting?

  1998cites this paper
• Cancer of the prostate. 1: Promoting men's healthcare needs.

  1998cites this paper
• Prostatic neoplasia: the importance of PIN, biological markers and screening tests for diagnosis

  1998cites this paper
• Apoptosis regulating genes in prostate cancer (review).

  1998cites this paper
• Androgen Deprivation for Prostatic Carcinoma: A Rationale for Choosing Components

  1998cites this paper
• Prostate, breast and gynecological cancer markers RAK with homology to HIV-1.

  1998cites this paper
• Therapeutic Dilemmas in Prostate Cancer: Justification for Watchful Waiting

  1998cites this paper
• The European randomized study of screening for prostate cancer

  1997cites this paper
• Screening for Prostatic Carcinoma: Case Finding is Not the Problem

  1997cites this paper
• Early detection of prostate cancer. Part II: Estimating the risks, benefits, and costs. American College of Physicians.

  1997cites this paper
• Basic science aspects of prostate cancer.

  1997cites this paper
• The molecular pathology of urological malignancies

  1997cites this paper
• Nuclear texture analysis: a new prognostic tool in metastatic prostate cancer.

  1996cites this paper
• Management dilemmas in prostate cancer.

  1996cites this paper
• Screening and early detection of prostate cancer will decrease morbidity and mortality from prostate cancer: the argument against.

  1996cites this paper
• Epidemiology of prostate cancer.

  1996cites this paper
• Attitudes and practices of primary care physicians for prostate cancer screening.

  1996cites this paper
• Absence of hepatic enzyme induction in prostate cancer patients receiving `Casodex' (bicalutamide)

  1996cites this paper
• THE PSYCHOLOGICAL EFFECTS OF BREAST SCREENING IN TERMS OF PATIENTS' PERCEIVED HEALTH ANXIETIES

  1996cites this paper
• Epidemiology, prevention and screening for prostate cancer.

  1996cites this paper
• European randomized study of screening for prostate cancer—The Rotterdam pilot studies

  1996cites this paper
• Screening for Prostate Cancer

  1996cites this paper
• Prostate cancer: To screen or not?

  1996cites this paper
• PSA as a Marker for Prostate Cancer: A Critical Review

  1996cites this paper
• Economic Aspects of Cancer Screening

  1996cites this paper
• Screening for Prostate Cancer: Practical Aspects

  1995cites this paper
• Screening, early detection, and treatment of prostate cancer: a European view.

  1995cites this paper
• Screening for Prostate Cancer: Background

  1995cites this paper
• Should Medicare provide reimbursement for prostate-specific antigen testing for early detection of prostate cancer? Part I: Framing the debate.

  1995cites this paper
• Should Medicare provide reimbursement for prostate-specific antigen testing for early detection of prostate cancer? Part III: Management strategies and outcomes.

  1995cites this paper
• Prostate disease: management options for the primary healthcare team. Report of a working party of the British Prostate Group.

  1995cites this paper
• Cancer of the male genital tract.

  1995cites this paper
• Detection of prostate cancer

  1995cites this paper
• Use of dexamethasone for ureteric obstruction in advanced prostate cancer: percutaneous nephrostomies can be avoided.

  1995cites this paper
• Carcinoma of prostate presenting as visceral (pulmonary) metastases.

  1995cites this paper
• Prostate cancer--what should be studied?

  1995cites this paper
• Need for hospital care and palliative treatment for prostate cancer treated with noncurative intent.

  1995cites this paper
• Trends in prostate cancer incidence and mortality rates in South Australia, 1977‐1993

  1995cites this paper
• Commentary on maximal androgen blockade in prostate cancer: A theory to put into practice?

  1995cites this paper
• Screening for cancer, 1995: an update.

  1995cites this paper
• Screening in general practice.

  1995cites this paper
• Serum concentrations of prostate specific antigen and its complex with alpha 1-antichymotrypsin before diagnosis of prostate cancer.

  1994cites this paper
• Screening for carcinoma of the prostate: a GP based study.

  1994cites this paper
• Karyometric analysis of intra-tumour heterogeneity in prostate adenocarcinoma.

  1994cites this paper
• The diagnostic value of colour Doppler flow in the peripheral zone of the prostate, with histological correlation.

  1994cites this paper
• Serum concentrations of prostate specific antigen and its complex with α1-antichymotrypsin before diagnosis of prostate cancer

  1994cites this paper
• Prostate cancer. Mortality and morbidity after non-curative treatment with aspects on diagnosis and treatment.

  1994cites this paper
• Trends in death rates and registration rates for prostate cancer in England and Wales.

  1994cites this paper
• Radical prostatectomy and prostate cancer screening: the need for national audit and research.

  1994cites this paper
• The Bristol prostate cancer pilot screening study--a 3-year follow-up.

  1994cites this paper
• Effect of alcohol on asthma

  1993cites this paper
• Screening for prostatic cancer.

  1993cites this paper
• Technical note: interstitial laser photocoagulation for the treatment of prostatic cancer.

  1993cites this paper
• Screening for prostatic cancer.

  1993cites this paper
• Screening for prostate cancer. How can patients give informed consent?

  1993cites this paper
• Screening for prostatic cancer.

  1993cites this paper
• Screening for prostatic cancer.

  1993cites this paper
• Costs of screening are important.

  1993cites this paper
• Prostate cancer and the role of color Doppler US.

  1993cites this paper